S. Sailer

2.3k total citations
137 papers, 1.7k citations indexed

About

S. Sailer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, S. Sailer has authored 137 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Molecular Biology and 23 papers in Physiology. Recurrent topics in S. Sailer's work include Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Lipid metabolism and disorders (19 papers) and Diet and metabolism studies (14 papers). S. Sailer is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Lipid metabolism and disorders (19 papers) and Diet and metabolism studies (14 papers). S. Sailer collaborates with scholars based in Austria, Germany and United States. S. Sailer's co-authors include H Braunsteiner, F. Sandhofer, Wolfgang Patsch, Josef R. Patsch, Christian Stumpf, Gerhard M. Kostner, H.‐J. Lisch, Ernst R. Werner, Katrin Watschinger and Markus A. Keller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

S. Sailer

125 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Sailer Austria 20 651 571 429 262 260 137 1.7k
John T. Gwynne United States 23 658 1.0× 886 1.6× 685 1.6× 301 1.1× 168 0.6× 46 2.2k
Gladys Perisutti United States 22 315 0.5× 585 1.0× 307 0.7× 216 0.8× 211 0.8× 42 1.2k
C.R. Park United States 14 998 1.5× 398 0.7× 491 1.1× 687 2.6× 108 0.4× 15 2.0k
C. R. Park United States 9 832 1.3× 209 0.4× 299 0.7× 427 1.6× 172 0.7× 10 1.4k
H Kather Germany 23 791 1.2× 243 0.4× 283 0.7× 767 2.9× 126 0.5× 128 1.9k
Agneta Mode Sweden 33 1.0k 1.6× 1.7k 2.9× 393 0.9× 502 1.9× 151 0.6× 92 3.4k
Erwin J. Landon United States 23 1.1k 1.8× 159 0.3× 214 0.5× 263 1.0× 248 1.0× 55 2.0k
Oscar B. Crofford United States 21 688 1.1× 425 0.7× 447 1.0× 605 2.3× 39 0.1× 33 1.5k
Walter N. Shaw United States 18 567 0.9× 309 0.5× 358 0.8× 514 2.0× 87 0.3× 31 1.3k
Thomas H. Claus United States 21 1.0k 1.5× 365 0.6× 418 1.0× 676 2.6× 75 0.3× 38 2.1k

Countries citing papers authored by S. Sailer

Since Specialization
Citations

This map shows the geographic impact of S. Sailer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sailer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sailer more than expected).

Fields of papers citing papers by S. Sailer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Sailer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sailer. The network helps show where S. Sailer may publish in the future.

Co-authorship network of co-authors of S. Sailer

This figure shows the co-authorship network connecting the top 25 collaborators of S. Sailer. A scholar is included among the top collaborators of S. Sailer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Sailer. S. Sailer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohlmaier, Benno, Kristijan Skok, Carolin Lackner, et al.. (2024). Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency. International Journal of Obesity. 48(12). 1818–1821.
2.
Lackner, Katharina, S. Sailer, Eric Wever, et al.. (2023). Alterations in ether lipid metabolism and the consequences for the mouse lipidome. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(4). 159285–159285. 8 indexed citations
3.
Wohlfarter, Yvonne, S. Sailer, Jakob Koch, et al.. (2022). Lost in promiscuity? An evolutionary and biochemical evaluation of HSD10 function in cardiolipin metabolism. Cellular and Molecular Life Sciences. 79(11). 562–562. 7 indexed citations
4.
Sailer, S., Katharina Lackner, Mia L. Pras‐Raves, et al.. (2022). Adaptations of the 3T3-L1 adipocyte lipidome to defective ether lipid catabolism upon Agmo knockdown. Journal of Lipid Research. 63(6). 100222–100222. 4 indexed citations
5.
Werner, Ernst R., Monica L. Fernández‐Quintero, Nicolas Hulo, et al.. (2022). Essential role of a conserved aspartate for the enzymatic activity of plasmanylethanolamine desaturase. Cellular and Molecular Life Sciences. 79(4). 214–214. 6 indexed citations
6.
Sailer, S., Stefan Coassin, Katharina Lackner, et al.. (2021). When the genome bluffs: a tandem duplication event during generation of a novel Agmo knockout mouse model fools routine genotyping. Cell & Bioscience. 11(1). 54–54. 14 indexed citations
7.
Werner, Ernst R., Markus A. Keller, S. Sailer, et al.. (2020). The TMEM189 gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens. Proceedings of the National Academy of Sciences. 117(14). 7792–7798. 87 indexed citations
8.
Oemer, Gregor, Jakob Koch, Yvonne Wohlfarter, et al.. (2020). Phospholipid Acyl Chain Diversity Controls the Tissue-Specific Assembly of Mitochondrial Cardiolipins. Cell Reports. 30(12). 4281–4291.e4. 79 indexed citations
9.
Werner, Ernst R., Markus A. Keller, S. Sailer, et al.. (2018). A novel assay for the introduction of the vinyl ether double bond into plasmalogens using pyrene-labeled substrates. Journal of Lipid Research. 59(5). 901–909. 27 indexed citations
10.
Hofmann-Preiß, K., Anne A. M. J. Becker, & S. Sailer. (1991). [Radiologic and clinical follow-up of central venous indwelling catheters in home parenteral nutrition].. PubMed. 18(6). 292–5. 5 indexed citations
11.
Lisch, H.‐J., et al.. (1982). Plasmalipoproteine bei Störungen der Schilddrüsenfunktion des Menschen. Journal of Molecular Medicine. 60(7). 337–342. 3 indexed citations
12.
Patsch, Wolfgang, S. Sailer, & H Braunsteiner. (1978). [Lecithin: cholesterol acyltransferase].. PubMed. 31(2). 25–32. 23 indexed citations
13.
Sailer, S., et al.. (1972). [Modification of the effect of insulin by DL-4 (2-hydroxy-3-isopropylaminopropoxy)-indole (Visken, LB 46) in normal and diabetic persons].. PubMed. 102(14). 510–4. 1 indexed citations
15.
Braunsteiner, H, et al.. (1966). [Cholelithiasis and latent diabetic metabolic condition].. PubMed. 96(2). 44–6. 4 indexed citations
16.
Sandhofer, F., et al.. (1965). Untersuchungen über die Post-Heparin-Lipoproteidlipase-Aktivität bei sechs Fällen von essentieller Hyperlipämie. DMW - Deutsche Medizinische Wochenschrift. 90(17). 755–759. 9 indexed citations
17.
Sailer, S., et al.. (1964). [EXPERIMENTAL TEST OF THE HEMOSTYPTIC EFFECT OF ESTRIOL SUCCINATE].. PubMed. 59. 181–3. 1 indexed citations
18.
Sailer, S., et al.. (1964). [CLINICAL EXAMINATION OF THE HEMOSTYPTIC EFFECTS OF ESTRIOL SUCCINATE].. PubMed. 59. 265–8. 1 indexed citations
19.
Braunsteiner, H, et al.. (1959). Über den Einfluß von Nikotinsäure und Heparin auf den Eisenstoffwechsel. Annals of Hematology. 5(3). 149–154. 2 indexed citations
20.
Sailer, S. & H Braunsteiner. (1959). [The significance of determination of blood cholinesterase activity].. PubMed. 40(5). 172–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026